Cosmo Bio Company,Limited (3386.T)

JPY 1144.0

(1.33%)

Operating Expenses Summary of Cosmo Bio Company,Limited

  • Cosmo Bio Company,Limited's latest annual operating expenses in 2023 was 2.73 Billion JPY , up 4.0% from previous year.
  • Cosmo Bio Company,Limited's latest quarterly operating expenses in 2024 Q2 was 708 Million JPY , up 4.11% from previous quarter.
  • Cosmo Bio Company,Limited reported a annual operating expenses of 2.62 Billion JPY in annual operating expenses 2022, up 0.57% from previous year.
  • Cosmo Bio Company,Limited reported a annual operating expenses of 2.6 Billion JPY in annual operating expenses 2021, up 8.75% from previous year.
  • Cosmo Bio Company,Limited reported a quarterly operating expenses of 708 Million JPY for 2024 Q2, up 4.11% from previous quarter.
  • Cosmo Bio Company,Limited reported a quarterly operating expenses of 638 Million JPY for 2023 Q1, down -13.32% from previous quarter.

Annual Operating Expenses Chart of Cosmo Bio Company,Limited (2023 - 2019)

Historical Annual Operating Expenses of Cosmo Bio Company,Limited (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 2.73 Billion JPY 4.0%
2022 2.62 Billion JPY 0.57%
2021 2.6 Billion JPY 8.75%
2020 2.39 Billion JPY -5.51%
2019 2.53 Billion JPY 0.0%

Peer Operating Expenses Comparison of Cosmo Bio Company,Limited

Name Operating Expenses Operating Expenses Difference
Shin Nippon Biomedical Laboratories, Ltd. 9.85 Billion JPY 72.299%
DNA Chip Research Inc. 324.19 Million JPY -742.392%
H.U. Group Holdings, Inc. 67.27 Billion JPY 95.941%
FALCO HOLDINGS Co., Ltd. 10.77 Billion JPY 74.645%
BML, Inc. 36.46 Billion JPY 92.51%
Human Metabolome Technologies, Inc. 639.4 Million JPY -327.118%
Precision System Science Co., Ltd. 1.9 Billion JPY -43.238%